Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 12Esophageal Squamous Cell Carcinoma 7Carcinoma, Non-Small-Cell Lung 6Rectal Neoplasms 5Uterine Cervical Neoplasms 4Pancreatic Neoplasms 4Head and Neck Neoplasms 3Glioblastoma 3Brain Neoplasms 3Stomach Neoplasms 2Nasopharyngeal Carcinoma 2Lung Neoplasms 2Hyperthermia 2Anus Neoplasms 2Adenocarcinoma 2Unresectable Stage III NSCLC 1Thymic epithelial tumor 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Recurrence 1Rare Diseases 1Prostatic Neoplasms 1Pleural Effusion, Malignant 1Ovarian Neoplasms 1Neoplasm Metastasis 1Mucositis 1Metastasising Cancer of Unknown Primary 1Medulloblastoma 1Lymphoma, B-Cell, Marginal Zone 1Locally Advanced Rectal Cancer 1

Interventions

CTLA-4 Antigen 2envafolimab 1Radiosurgery 1Radiation 1Paclitaxel 1Doxorubicin 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Diabetes Mellitus, Insulin-Dependent, 12 × Radiation × Clear all
NCT05490719 2024-05-21

A Phase II Study of CRT Combined With QL1706 in ESCC Patients

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Unknown
39 enrolled
Gastrointestinal

Diabetes Mellitus, Insulin-Dependent, 12, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡